CAS: 1104083-27-3 - 1,1-Dimethylethyl 3-hydroxy-3-methyl-1-piperidinecarboxylate
Formula:C11H21NO3
InChI:InChI=1S/C11H21NO3/c1-10(2,3)15-9(13)12-7-5-6-11(4,14)8-12/h14H,5-8H2,1-4H3
InChI key:InChIKey=IWWAIZZOPVWORI-UHFFFAOYSA-N
SMILES:O=C(OC(C)(C)C)N1CCCC(O)(C)C1
- Synonyms:
- 1-Piperidinecarboxylic acid, 3-hydroxy-3-methyl-, 1,1-dimethylethyl ester
- tert-Butyl 3-hydroxy-3-methylpiperidine-1-carboxylate
- 1,1-Dimethylethyl 3-hydroxy-3-methyl-1-piperidinecarboxylate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
tert-butyl 3-hydroxy-3-methylpiperidine-1-carboxylate REF: IN-DA008TUVCAS: 1104083-27-3 | 95% | 25.00 €~186.00 € | Mon 16 Dec 24 | |
tert-Butyl 3-hydroxy-3-methylpiperidine-1-carboxylate REF: 10-F465183CAS: 1104083-27-3 | 95.0% | 20.00 €~258.00 € | Tue 17 Dec 24 | |
tert-Butyl 3-hydroxy-3-methyl-piperidine-1-carboxylate REF: 3D-EUB08327CAS: 1104083-27-3 | Min. 95% | - - - | Discontinued product |
tert-butyl 3-hydroxy-3-methylpiperidine-1-carboxylate
CAS:1104083-27-3
Formula:
C11H21NO3
Purity:
95%
Color and Shape:
Solid
Molecular weight:
215.2893
Ref: IN-DA008TUV
1g | 41.00 € | ||
5g | 95.00 € | ||
10g | 140.00 € | ||
25g | 186.00 € | ||
100mg | 25.00 € | ||
250mg | 25.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
tert-Butyl 3-hydroxy-3-methylpiperidine-1-carboxylate
CAS:1104083-27-3
Purity:
95.0%
Color and Shape:
Liquid, No data available.
Molecular weight:
215.29299926757812
Ref: 10-F465183
1g | 20.00 € | ||
5g | 62.00 € | ||
10g | 114.00 € | ||
25g | 258.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
tert-Butyl 3-hydroxy-3-methyl-piperidine-1-carboxylate
CAS:1104083-27-3
Versatile small molecule scaffold
Formula:
C11H21NO3
Purity:
Min. 95%
Molecular weight:
215.29 g/mol
Ref: 3D-EUB08327
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information | |
2500mg | Discontinued | Request information |